Tullia Lindsten

Active 1982–2025

59
Papers
28,605
Citations
57
h-index
59
i10-index

Citations

Citations per year for Tullia Lindsten1982: 1 citations1984: 1 citations1985: 48 citations1986: 41 citations1987: 43 citations1988: 38 citations1989: 21 citations1990: 32 citations1991: 63 citations1992: 80 citations1993: 88 citations1994: 156 citations1995: 195 citations1996: 221 citations1997: 168 citations1998: 200 citations1999: 166 citations2000: 147 citations2001: 234 citations2002: 457 citations2003: 524 citations2004: 449 citations2005: 462 citations2006: 425 citations2007: 431 citations2008: 386 citations2009: 353 citations2010: 413 citations2011: 315 citations2012: 333 citations2013: 409 citations2014: 290 citations2015: 319 citations2016: 307 citations2017: 287 citations2018: 218 citations2019: 595 citations2020: 622 citations2021: 574 citations2022: 416 citations2023: 302 citations2024: 406 citations2025: 158 citations2026: 3 citations1983: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,034 citing papers, 39.9% of this breakdownChina: 1,103 citing papers, 8.7% of this breakdownUnited Kingdom: 672 citing papers, 5.3% of this breakdownGermany: 611 citing papers, 4.8% of this breakdownFrance: 533 citing papers, 4.2% of this breakdownAustralia: 491 citing papers, 3.9% of this breakdownJapan: 452 citing papers, 3.6% of this breakdownCanada: 439 citing papers, 3.5% of this breakdownItaly: 344 citing papers, 2.7% of this breakdownSwitzerland: 227 citing papers, 1.8% of this breakdownSpain: 213 citing papers, 1.7% of this breakdownSouth Korea: 203 citing papers, 1.6% of this breakdown
0%39.9%Other 18.3%

Fields

  • Biochemistry, Genetics and Molecular Biology45%
  • Medicine29.5%
  • Immunology and Microbiology21%
  • Neuroscience1.9%
  • Agricultural and Biological Sciences0.7%
  • Pharmacology, Toxicology and Pharmaceutics0.4%
  • Other1.5%

Topics

  • Cell death mechanisms and regulation8.1%
  • Immune Cell Function and Interaction6.9%
  • Autophagy in Disease and Therapy5.6%
  • T-cell and B-cell Immunology5.4%
  • Mitochondrial Function and Pathology3.3%
  • Immunotherapy and Immune Responses2.9%
  • Other67.8%

Coauthors

All papers

Open in search
  1. Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death

    Authors: , , , , , , , , , - Science 2001 cited by 3,968

  2. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin

    Authors: , , , , , , , , , , , , , , , , , - Nature Immunology 2005 cited by 1,242

  3. The Transcription Factors T-bet and Eomes Control Key Checkpoints of Natural Killer Cell Maturation

    Authors: , , , , , , , - Immunity 2012 cited by 718

  4. Serine Catabolism Regulates Mitochondrial Redox Control during Hypoxia

    Authors: , , , , , , , , , , , , , , - Cancer Discovery 2014 cited by 452

  5. The Combined Functions of Proapoptotic Bcl-2 Family Members Bak and Bax Are Essential for Normal Development of Multiple Tissues

    Authors: , , , , , , , , , , , , , , , , , , , , - Molecular Cell 2000 cited by 1,474

  6. Control of Effector CD8 + T Cell Function by the Transcription Factor Eomesodermin

    Authors: , , , , , , , , , , , , , , , , - Science 2003 cited by 999

  7. Growth Factor Regulation of Autophagy and Cell Survival in the Absence of Apoptosis

    Authors: , , , , , , - Cell 2005 cited by 1,487

  8. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c

    Authors: , , , , , , , - Genes & Development 2000 cited by 1,255

  9. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death

    Authors: , , , , , , , , - Cell 1993 cited by 3,116

  10. GCN2 sustains mTORC1 suppression upon amino acid deprivation by inducing Sestrin2

    Authors: , , , , , , , - Genes & Development 2015 cited by 276

  11. BCL-2, BCL-XL Sequester BH3 Domain-Only Molecules Preventing BAX- and BAK-Mediated Mitochondrial Apoptosis

    Authors: , , , , , , - Molecular Cell 2001 cited by 1,692

  12. Ulk1 plays a critical role in the autophagic clearance of mitochondria and ribosomes during reticulocyte maturation

    Authors: , , , , , , , , - Blood 2008 cited by 558

  13. Basis of CTLA-4 function in regulatory and conventional CD4+ T cells

    Authors: , , , , , , , , , , , - Blood 2012 cited by 248

  14. Ammonia-induced autophagy is independent of ULK1/ULK2 kinases

    Authors: , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 cited by 373

  15. Bax regulates primary necrosis through mitochondrial dynamics

    Authors: , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 cited by 289

  16. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL

    Authors: , , , , , , - Immunity 1995 cited by 1,206

  17. The Noncanonical Role of ULK/ATG1 in ER-to-Golgi Trafficking Is Essential for Cellular Homeostasis

    Authors: , , , , , , , , , , , , , , , , - Molecular Cell 2016 cited by 186

  18. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.

    Authors: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1989 cited by 659

  19. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression.

    Authors: , , , , - Molecular and Cellular Biology 1987 cited by 526

  20. Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis

    Authors: , , , , , , - The Journal of Cell Biology 2003 cited by 585

  21. Anomalous Type 17 Response to Viral Infection by CD8 + T Cells Lacking T-bet and Eomesodermin

    Authors: , , , , , , , , , - Science 2008 cited by 379

  22. Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells

    Authors: , , , , , , - The Journal of Immunology 1997 cited by 341

  23. Characterization of CTLA-4 structure and expression on human T cells.

    Authors: , , , , , , , , , , , - The Journal of Immunology 1993 cited by 320

  24. In vivo, Argonaute-bound microRNAs exist predominantly in a reservoir of low molecular weight complexes not associated with mRNA

    Authors: , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 cited by 122